Evidence map›Paper›PMID 41530957›Full record

ReviewMedical science monitor : international medical journal of experimental and clinical research2026

Roles of the Altitude-Adapted Immune Microenvironment in Pulmonary Vascular Remodeling in High-Altitude Pulmonary Hypertension: A Review.

Yonghui Li, Haijing Xing, Yunxing Liu, Fu Li, Dan Yang, Qian Miao, Huaan Li, Xinxing Li, Shuhang Yang, Yi Fu

Abstract readReview
In one paragraph

Review in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yonghui LiYunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Haijing XingYunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Yunxing LiuYunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Fu LiZhaotong Hospital of Traditional Chinese Medicine, The Fifth Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Zhaotong, Yunnan, China.
Dan YangYunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Qian MiaoDepartment of Pulmonary Diseases, Kunming Hospital of Traditional Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, China.
Huaan LiDepartment of Pulmonary Diseases, Kunming Hospital of Traditional Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, China.
Xinxing LiDepartment of Pulmonary Diseases, Kunming Hospital of Traditional Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, China.
Shuhang YangDepartment of Pulmonary Diseases, Kunming Hospital of Traditional Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan, China.
Yi FuYunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-altitude pulmonary hypertension (HAPH) is a debilitating condition caused by chronic hypobaric hypoxia at high altitudes, leading to progressive pulmonary vascular remodeling and right heart failure. The altitude-adapted immune microenvironment plays a pivotal but underappreciated role in HAPH progression: innate immune cells mediate early endothelial damage and proinflammatory signaling, while adaptive immune dysregulation sustains chronic inflammation. This review focuses on hypoxic-induced altitude-adapted immune microenvironment alterations - including immune cell phenotypic reprogramming, metabolic shifts, and spatial reorganization - and their roles in driving endothelial dysfunction, smooth muscle cell proliferation, and fibroblast activation. It also explores immune-cell crosstalk with vascular cells via paracrine signaling/extracellular vesicles, and highlights therapeutic strategies. This article aims to review the roles of hypoxia, inflammation, and oxidative stress in vascular remodeling in HAPH.

Indexed as

Altitude SicknessHypertension, PulmonaryVascular RemodelingAdaptation, PhysiologicalAltitudeAnimalsHumansHypoxiaInflammationOxidative Stress

Identifiers

PMID41530957
PMCPMC12818017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.